BR9103036A - Composto,formulacao farmaceutica e processo para a preparacao do composto - Google Patents
Composto,formulacao farmaceutica e processo para a preparacao do compostoInfo
- Publication number
- BR9103036A BR9103036A BR919103036A BR9103036A BR9103036A BR 9103036 A BR9103036 A BR 9103036A BR 919103036 A BR919103036 A BR 919103036A BR 9103036 A BR9103036 A BR 9103036A BR 9103036 A BR9103036 A BR 9103036A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- preparation
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/18—Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/64—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/34—Sulfur atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55422690A | 1990-07-17 | 1990-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9103036A true BR9103036A (pt) | 1992-04-28 |
Family
ID=24212538
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR919103036A BR9103036A (pt) | 1990-07-17 | 1991-07-16 | Composto,formulacao farmaceutica e processo para a preparacao do composto |
Country Status (20)
Country | Link |
---|---|
US (1) | US5302724A (pt) |
EP (1) | EP0467613A1 (pt) |
JP (1) | JPH04234382A (pt) |
KR (1) | KR920002579A (pt) |
CN (1) | CN1058401A (pt) |
AU (1) | AU640499B2 (pt) |
BR (1) | BR9103036A (pt) |
CA (1) | CA2047103A1 (pt) |
CS (1) | CS219291A3 (pt) |
FI (1) | FI913432A (pt) |
HU (1) | HUT58698A (pt) |
IE (1) | IE912488A1 (pt) |
IL (1) | IL98784A0 (pt) |
MX (1) | MX9100165A (pt) |
NO (1) | NO912773L (pt) |
NZ (1) | NZ238911A (pt) |
PT (1) | PT98320A (pt) |
RU (1) | RU2022963C1 (pt) |
YU (1) | YU124291A (pt) |
ZA (1) | ZA915371B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5254582A (en) * | 1992-02-05 | 1993-10-19 | Eli Lilly And Company | Antitumor compositions and methods |
US5169860A (en) * | 1992-03-13 | 1992-12-08 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
US5387681A (en) * | 1992-08-19 | 1995-02-07 | Eli Lilly And Company | Synthesis of bicyclic aromatic sulfonic acids sulfonyl chlorides and sulfonamides |
US5300499A (en) * | 1992-09-02 | 1994-04-05 | Allergan, Inc. | 5-substituted 3-thiophene sulfonamides as antiglaucoma agents |
ZA941500B (en) * | 1993-03-10 | 1995-09-04 | Lilly Co Eli | Antitumor compositions and methods of treatment |
AU709107B2 (en) * | 1996-08-22 | 1999-08-19 | Dong Wha Pharmaceutical Industrial Co., Ltd. | Arylsulfonylimidazolone derivatives as an antitumor agent |
AU4799797A (en) * | 1996-10-04 | 1998-04-24 | Eli Lilly And Company | Antitumor compositions and methods of treatment |
US6646009B2 (en) | 2001-02-28 | 2003-11-11 | Temple University — Of Commonwealth System of Higher Education | N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
TWI281916B (en) * | 2001-10-25 | 2007-06-01 | Lilly Co Eli | Antitumor compounds and methods |
ATE517626T1 (de) * | 2002-02-28 | 2011-08-15 | Univ Temple | Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen |
CN103450149B (zh) * | 2012-06-01 | 2015-10-14 | 中国科学院上海有机化学研究所 | 苯基噻吩磺酰胺类化合物及其制备方法和用途 |
SI3578547T1 (sl) | 2015-02-16 | 2021-09-30 | The University Of Queensland | Sulfonilsečnine in sorodne spojine ter njihova uporaba |
EP3872070A1 (en) | 2016-04-18 | 2021-09-01 | Novartis AG | Compounds and compositions for treating conditions associated with nlrp activity |
RS62910B1 (sr) | 2017-07-07 | 2022-03-31 | Inflazome Ltd | Nova jedinjenja sulfonamid karboksamida |
AU2018317798A1 (en) | 2017-08-15 | 2020-02-13 | Inflazome Limited | Sulfonylureas and sulfonylthioureas as NLRP |
TW201910317A (zh) | 2017-08-15 | 2019-03-16 | 愛爾蘭商英弗雷佐姆有限公司 | 新穎化合物 |
WO2019034693A1 (en) | 2017-08-15 | 2019-02-21 | Inflazome Limited | SULFONYLURATES AND SULFONYLTHIOURES AS INHIBITORS OF NLRP3 |
WO2019166619A1 (en) | 2018-03-02 | 2019-09-06 | Inflazome Limited | Novel compounds |
CN109384764B (zh) * | 2018-12-12 | 2021-09-03 | 中国科学院上海有机化学研究所 | 苯基噻吩磺酰胺类化合物、药物组合物、其制备方法和应用 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3124597A (en) * | 1964-03-10 | |||
US3083207A (en) * | 1963-03-26 | Indolinesulfonylureas | ||
DE1144259B (de) * | 1956-05-29 | 1963-02-28 | Hoechst Ag | Verfahren zur Herstellung von Sulfonylharnstoffen |
US3097241A (en) * | 1956-08-10 | 1963-07-09 | Hoechst Ag | Nu-cyclohexane-sulphonyl-n'-(beta-phenylethyl)-urea |
CH361010A (de) * | 1957-05-24 | 1962-03-31 | Geigy Ag J R | Verfahren zur Herstellung von N'-substituierten N-Thiophensulfonylharnstoffen |
US3013072A (en) * | 1958-09-02 | 1961-12-12 | Pfizer & Co C | Novel process for the production of sulfonylureas |
US2979437A (en) * | 1958-09-02 | 1961-04-11 | Pfizer & Co C | Substituted styryl, and thienylethenyl, pyridylethenyl sulfonylureas and method of treating diabetes |
US3097242A (en) * | 1960-06-29 | 1963-07-09 | Olin Mathieson | Hydrindene sulfonylureas |
DE1159937B (de) * | 1960-06-29 | 1963-12-27 | Heyden Chem Fab | Verfahren zur Herstellung von Hydrindensulfonylharnstoffen |
DE1240866B (de) * | 1961-06-29 | 1967-05-24 | Heyden Chem Fab | Verfahren zur Herstellung von Indolin-6-sulfonylharnstoffen |
US3102121A (en) * | 1961-06-29 | 1963-08-27 | Olin Mathieson | Novel cumaransulfonylureas and 2,3-dihydrothionaphthenesulfonylureas |
US3155721A (en) * | 1961-11-30 | 1964-11-03 | Lilly Co Eli | Novel sulfonylureas |
GB1050447A (pt) * | 1962-04-11 | |||
US3849110A (en) * | 1963-01-07 | 1974-11-19 | Lilly Co Eli | Herbicidal method employing aryl-sulfonylureas or salts thereof |
US3736122A (en) * | 1969-04-10 | 1973-05-29 | C Tung | Method of controlling plant growth |
US4398939A (en) * | 1980-06-03 | 1983-08-16 | E. I. Du Pont De Nemours And Company | Herbicidal thiophenesulfonamides |
US4634465A (en) * | 1982-07-16 | 1987-01-06 | Ciba-Geigy Corporation | Fused N-phenylsulfonyl-N'-pyrimidinylureas and N-phenylsulfonyl-N'triazinylureas |
AU1862083A (en) * | 1982-09-02 | 1984-03-08 | Duphar International Research B.V. | Tumor growth inhibitors |
US4471757A (en) * | 1983-03-15 | 1984-09-18 | Rogers William W | Log support for fireplace |
IT1161220B (it) * | 1983-04-21 | 1987-03-18 | Montedison Spa | Diidro-benzofurano derivati ad attivita' erbicida |
US4620868A (en) * | 1983-12-27 | 1986-11-04 | Ishihara Sangyo Kaisha, Ltd. | N-[(4,6-dimethoxypyrimidin-2-yl)aminocarbonyl]-3[halo-substituted ethenyl (or propenyl)]-2-thiophenesulfonamides useful as herbicides |
CA1208561A (en) * | 1984-01-19 | 1986-07-29 | Marius S. Brouwer | Pharmaceutical compositions containing benzoylurea compounds |
US4845128A (en) * | 1984-06-27 | 1989-07-04 | Eli Lilly And Company | N([(4-trifluoromethylphenyl)amino]carbonyl)benzene sulfonamides |
US4861366A (en) * | 1984-08-27 | 1989-08-29 | E. I. Du Pont De Nemours And Company | Herbicidal acetals and ketals |
DK88186A (da) * | 1985-03-01 | 1986-09-02 | Duphar Int Res | Benzoylurinstofderivater med antitumoraktivitet |
GR862353B (en) * | 1985-09-23 | 1987-01-19 | Lilly Co Eli | Anti-tumor method and compounds |
EP0228237B1 (en) * | 1985-12-24 | 1989-11-23 | Merck & Co. Inc. | Substituted thiophene-2-sulfonamide antiglaucoma agents |
CA1331464C (en) * | 1987-05-12 | 1994-08-16 | Eli Lilly And Company | Anti-tumor method and compounds |
-
1991
- 1991-07-10 NZ NZ238911A patent/NZ238911A/xx unknown
- 1991-07-10 IL IL98784A patent/IL98784A0/xx unknown
- 1991-07-10 ZA ZA915371A patent/ZA915371B/xx unknown
- 1991-07-11 MX MX9100165A patent/MX9100165A/es unknown
- 1991-07-15 KR KR1019910012031A patent/KR920002579A/ko not_active Application Discontinuation
- 1991-07-15 CS CS912192A patent/CS219291A3/cs unknown
- 1991-07-15 HU HU912375A patent/HUT58698A/hu unknown
- 1991-07-15 EP EP91306373A patent/EP0467613A1/en not_active Withdrawn
- 1991-07-15 AU AU80444/91A patent/AU640499B2/en not_active Ceased
- 1991-07-15 PT PT98320A patent/PT98320A/pt not_active Application Discontinuation
- 1991-07-15 NO NO91912773A patent/NO912773L/no unknown
- 1991-07-16 CN CN91104931A patent/CN1058401A/zh active Pending
- 1991-07-16 YU YU124291A patent/YU124291A/sh unknown
- 1991-07-16 IE IE248891A patent/IE912488A1/en unknown
- 1991-07-16 BR BR919103036A patent/BR9103036A/pt not_active Application Discontinuation
- 1991-07-16 RU SU915001153A patent/RU2022963C1/ru active
- 1991-07-16 FI FI913432A patent/FI913432A/fi unknown
- 1991-07-16 CA CA002047103A patent/CA2047103A1/en not_active Abandoned
- 1991-07-16 JP JP3175066A patent/JPH04234382A/ja active Pending
-
1992
- 1992-04-29 US US07/875,902 patent/US5302724A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
ZA915371B (en) | 1993-03-31 |
KR920002579A (ko) | 1992-02-28 |
JPH04234382A (ja) | 1992-08-24 |
HU912375D0 (en) | 1991-12-30 |
CS219291A3 (en) | 1992-09-16 |
AU8044491A (en) | 1992-01-23 |
FI913432A0 (fi) | 1991-07-16 |
FI913432A (fi) | 1992-01-18 |
EP0467613A1 (en) | 1992-01-22 |
CN1058401A (zh) | 1992-02-05 |
NO912773L (no) | 1992-01-20 |
IE912488A1 (en) | 1992-01-29 |
NO912773D0 (no) | 1991-07-15 |
US5302724A (en) | 1994-04-12 |
NZ238911A (en) | 1993-10-26 |
HUT58698A (en) | 1992-03-30 |
AU640499B2 (en) | 1993-08-26 |
MX9100165A (es) | 1992-02-28 |
RU2022963C1 (ru) | 1994-11-15 |
PT98320A (pt) | 1992-05-29 |
YU124291A (sh) | 1994-01-20 |
IL98784A0 (en) | 1992-07-15 |
CA2047103A1 (en) | 1992-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR1100850A (pt) | Composto, processo para a preparação de um composto, e, composição farmacêutica | |
BR9204361A (pt) | Composto e processo para sua preparacao formulacao farmaceutica e intermediario | |
BR9501770A (pt) | Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto | |
BR1100323A (pt) | Composto, uso de um composto, composição farmacêutica e processo para preparar um composto | |
BR9000040A (pt) | Derivados de 3-aril-pirrolidin-2,4-diona,processo para sua preparacao,composicoes inseticidas,processos para combater insetos e para a preparacao de composicoes e aplicacao | |
BR9504509A (pt) | Composto processo para sua preparaçao e formulaçao farmaceûtica | |
BR9600821A (pt) | Composto formulação farmacêutica e processo para a preparação de um composto | |
BR9301137A (pt) | Composto,formulacao farmaceutica,sulfonamida e processo para sua preparacao | |
BR9200951A (pt) | Compostos, processo para sua producao,preparacoes farmaceuticas e uso | |
BR9202522A (pt) | Composto,formulacao farmaceutica e processo para preparar um composto | |
BR9404809A (pt) | Composto, uso, formulação farmacêutica e processo para preparar um composto | |
BR9103036A (pt) | Composto,formulacao farmaceutica e processo para a preparacao do composto | |
BR9004852A (pt) | Composto,processo para sua preparacao,sua aplicacao e composicao farmaceutica | |
BR9101121A (pt) | Composto,processo para sua preparacao,suas aplicacoes,e preparado farmaceutico | |
BR9407306A (pt) | Composição farmacêutica para a administação oral e processo para preparar a mesma | |
BR9301342A (pt) | Composto,formulacao e composicao farmaceutica,processo para preparar um composto | |
BR9202325A (pt) | Composto,processo para a sua preparacao,preparado farmaceutico e processo para a sua preparacao | |
BR9303456A (pt) | Compostos,processo para sua preparacao,medicamentos,processo para sua preparacao e emprego | |
BR9305161A (pt) | Composto, composição farmacêutica e processo para a preparação do composto | |
BR9302389A (pt) | Composto,formulacao farmaceutica e processo para preparar o composto | |
BR9301273A (pt) | Composto,formulacao farmaceutica,processo para preparar um composto e composto obtido | |
BR9602025A (pt) | Composto composição farmacêutica uso e processo para a preparação de um composto | |
BR9301676A (pt) | Processo para a preparacao de 1,1,1,4,4,4-hexafluorbutano e compostos obtidos | |
BR8907141A (pt) | Composto,processo para a preparacao do mesmo e inseticida | |
BR9406924A (pt) | Composto processo para preparar o mesmo formulaçao farmaceutica e uso de um composto |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD3 | Appl. lapsed due to non-payment of renewal fee |